Amgen Inc. EVP & CFO Files Initial Statement of Beneficial Ownership (Form 3)

Initial Statement of Beneficial Ownership (Form 3) Analysis

Executive Overview:

• Reporting Owner: Thomas J.W. Dittrich
• Position: Executive Vice President & Chief Financial Officer
• Issuer: Amgen Inc. ($AMGN)
• Effective Date: September 1, 2026

---

Reported Holdings Summary

1. Non-Derivative Securities:

   • Common Stock (RSUs): 16,860 shares held directly.
   • Vesting Terms: Granted under the Second Amended and Restated 2009 Equity Incentive Plan; vests in four equal annual installments of 25% commencing August 7, 2027.

2. Derivative Securities:

   • Non-Qualified Stock Options (Right to Buy): 17,201 underlying common shares.
   • Exercise Price: $410.95 per share.
   • Expiration Date: August 7, 2036.
   • Vesting Terms: Vests and becomes exercisable in four equal annual installments of 25% commencing August 7, 2027.

---

Strategic Takeaway

This Form 3 filing establishes the initial ownership baseline for incoming EVP & CFO Thomas J.W. Dittrich following his appointment. The equity package reflects standard multi-year retention alignment through RSUs and market-price stock options.